D-Index & Metrics Best Publications
Research.com 2023 Best Scientist Award Badge
Medicine
France
2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 158 Citations 96,932 1,287 World Ranking 457 National Ranking 10
Best Scientists D-index 158 Citations 96,982 1,443 World Ranking 895 National Ranking 16

Research.com Recognitions

Awards & Achievements

2023 - Research.com Best Scientist Award

2023 - Research.com Medicine in France Leader Award

2022 - Research.com Best Scientist Award

2022 - Research.com Medicine in France Leader Award

Overview

What is he best known for?

The fields of study Maxime Dougados is best known for:

  • Rheumatoid arthritis
  • Clinical trial
  • Statistics

His study deals with a combination of Internal medicine and Family medicine. Alternative medicine and Placebo are two areas of study in which Maxime Dougados engages in interdisciplinary work. He regularly ties together related areas like Randomized controlled trial in his Pathology studies. He integrates many fields, such as Randomized controlled trial and Alternative medicine, in his works. Maxime Dougados performs integrative Rheumatoid arthritis and Rheumatism research in his work. He integrates Rheumatism with Rheumatology in his study. Maxime Dougados merges many fields, such as Rheumatology and Rheumatoid arthritis, in his writings. He conducts interdisciplinary study in the fields of Osteoarthritis and Arthroplasty through his works. Maxime Dougados performs integrative Arthroplasty and Osteoarthritis research in his work.

His most cited work include:

  • EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update (784 citations)
  • OARSI recommendations for the management of hip and knee osteoarthritis, Part I: Critical appraisal of existing treatment guidelines and systematic review of current research evidence (714 citations)
  • European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update (688 citations)

What are the main themes of his work throughout his whole career to date

His Surgery study in the realm of Radiography connects with subjects such as Nuclear medicine. Maxime Dougados undertakes interdisciplinary study in the fields of Surgery and Pathology through his research. His research on Pathology often connects related areas such as Osteoarthritis. In his articles, Maxime Dougados combines various disciplines, including Nuclear medicine and Radiography. Maxime Dougados is researching Alternative medicine as part of the investigation of Osteoarthritis and Placebo. In his works, Maxime Dougados conducts interdisciplinary research on Placebo and Alternative medicine. Maxime Dougados connects Internal medicine with Gastroenterology in his research. Maxime Dougados performs integrative Gastroenterology and Internal medicine research in his work. Maxime Dougados incorporates Rheumatoid arthritis and Rheumatology in his research.

Maxime Dougados most often published in these fields:

  • Internal medicine (73.68%)
  • Pathology (48.87%)
  • Alternative medicine (48.12%)

What were the highlights of his more recent work (between 2014-2021)?

  • Internal medicine (91.67%)
  • Physical therapy (58.33%)
  • Rheumatoid arthritis (41.67%)

In recent works Maxime Dougados was focusing on the following fields of study:

Combining a variety of fields, including Odds ratio, Confidence interval and Logistic regression, are what the author presents in his essays. Maxime Dougados performs multidisciplinary studies into Confidence interval and Odds ratio in his work. Maxime Dougados merges many fields, such as Internal medicine and Family medicine, in his writings. He merges Family medicine with Internal medicine in his research. His research ties Fibromyalgia and Physical therapy together. He regularly links together related areas like Physical therapy in his Fibromyalgia studies. He performs multidisciplinary study in Rheumatoid arthritis and Rheumatism in his work. Maxime Dougados integrates several fields in his works, including Rheumatism and Rheumatoid arthritis. Disease connects with themes related to Antirheumatic Agents in his study.

Between 2014 and 2021, his most popular works were:

  • EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update (784 citations)
  • European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update (688 citations)
  • Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registry (57 citations)

In his most recent research, the most cited works focused on:

  • Rheumatoid arthritis
  • Psoriatic arthritis
  • Adalimumab

Maxime Dougados undertakes interdisciplinary study in the fields of Internal medicine and Family medicine through his research. In his research, he undertakes multidisciplinary study on Family medicine and Internal medicine. Maxime Dougados performs integrative Rheumatoid arthritis and Rheumatism research in his work. In his articles, Maxime Dougados combines various disciplines, including Rheumatism and Rheumatoid arthritis. Maxime Dougados frequently studies issues relating to Expert opinion and Intensive care medicine. His Intensive care medicine research extends to Expert opinion, which is thematically connected. His work in Disease is not limited to one particular discipline; it also encompasses Antirheumatic Agents. His research on Antirheumatic Agents often connects related areas such as Disease. He integrates many fields in his works, including Psoriatic arthritis and Ankylosing spondylitis.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection

M Rudwaleit;D van der Heijde;R Landewé;J Listing.
Annals of the Rheumatic Diseases (2009)

3652 Citations

The European spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy

Dougados M;van der Linden S;Juhlin R;Huitfeldt B.
Arthritis & Rheumatism (1991)

3251 Citations

Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy : Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks

Stanley B Cohen;Paul Emery;Maria W Greenwald;Maxime Dougados.
Arthritis & Rheumatism (2006)

2287 Citations

2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

Jasvinder A. Singh;Daniel E. Furst;Aseem Bharat;Jeffrey R. Curtis.
Arthritis Care and Research (2012)

2162 Citations

Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition.

Mark C Genovese;Jean-Claude Becker;Michael Schiff;Michael Luggen.
The New England Journal of Medicine (2005)

1706 Citations

The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis

J. Sieper;M. Rudwaleit;X. Baraliakos;J. Brandt.
Annals of the Rheumatic Diseases (2009)

1684 Citations

The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general

M. Rudwaleit;D.M.F.M. van der Heijde;R.B.M. Landewé;N. Akkoc.
Annals of the Rheumatic Diseases (2011)

1579 Citations

Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig.

Joel M Kremer;Rene Westhovens;Marc Leon;Eduardo Di Giorgio.
The New England Journal of Medicine (2003)

1364 Citations

Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force

Josef S Smolen;Ferdinand C Breedveld;Gerd R Burmester;Vivian Bykerk.
Annals of the Rheumatic Diseases (2016)

1326 Citations

EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

Bernard Combe;Robert Landewé;Cedric Lukas;Horatio D Bolosiu.
Annals of the Rheumatic Diseases (2006)

1125 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Maxime Dougados

Paul Emery

Paul Emery

University of Leeds

Publications: 341

Désirée van der Heijde

Désirée van der Heijde

Leiden University Medical Center

Publications: 319

Robert Landewé

Robert Landewé

University of Amsterdam

Publications: 249

Joachim Sieper

Joachim Sieper

Charité - University Medicine Berlin

Publications: 224

Josef S. Smolen

Josef S. Smolen

Medical University of Vienna

Publications: 199

Tore K. Kvien

Tore K. Kvien

University of Oslo

Publications: 181

Xenofon Baraliakos

Xenofon Baraliakos

Ruhr University Bochum

Publications: 173

Philip J. Mease

Philip J. Mease

University of Washington

Publications: 173

Laure Gossec

Laure Gossec

Sorbonne University

Publications: 172

Walter P. Maksymowych

Walter P. Maksymowych

University of Alberta

Publications: 161

Bruno Fautrel

Bruno Fautrel

Université Paris Cité

Publications: 159

David J. Hunter

David J. Hunter

University of Oxford

Publications: 157

Mikkel Østergaard

Mikkel Østergaard

University of Copenhagen

Publications: 155

Bernard Combe

Bernard Combe

University of Montpellier

Publications: 146

Alain Saraux

Alain Saraux

Grenoble Alpes University

Publications: 142

Robin Christensen

Robin Christensen

University of Southern Denmark

Publications: 135

Trending Scientists

Sjaak Brinkkemper

Sjaak Brinkkemper

Utrecht University

Neil Wallace

Neil Wallace

Pennsylvania State University

Sean B. Leen

Sean B. Leen

National University of Ireland, Galway

Thomas Haertlé

Thomas Haertlé

INRAE : Institut national de recherche pour l'agriculture, l'alimentation et l'environnement

Rob C. Hoeben

Rob C. Hoeben

Leiden University Medical Center

Bernd Hoffmann

Bernd Hoffmann

Friedrich-Loeffler-Institut

Thomas A. Neumann

Thomas A. Neumann

Goddard Space Flight Center

Jiang-Ning Zhou

Jiang-Ning Zhou

University of Science and Technology of China

Suzanne L. Topalian

Suzanne L. Topalian

Johns Hopkins University

Donald E. Mosier

Donald E. Mosier

Scripps Research Institute

Thomas F. Cash

Thomas F. Cash

Old Dominion University

Stafford L. Lightman

Stafford L. Lightman

University of Bristol

Susheel Kodali

Susheel Kodali

Columbia University Medical Center

Christine Griffin

Christine Griffin

University of Bath

Lisa A. Brenner

Lisa A. Brenner

University of Colorado Anschutz Medical Campus

Keith Matthews

Keith Matthews

California Institute of Technology

Something went wrong. Please try again later.